Marinus Pharma CS (MRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 47,105 | 8,416 | 8,830 | 10,037 | N/A |
| Other current assets | 0 | 932 | 518 | 0 | 0 |
| TOTAL | $47,544 | $9,449 | $10,542 | $11,799 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 9 | 11 | 14 | 16 | N/A |
| Other Non-Current Assets | 8 | 19 | 9 | 9 | 0 |
| TOTAL | $17 | $30 | $23 | $25 | $N/A |
| Total Assets | $47,561 | $9,479 | $10,565 | $11,824 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 827 | 1,743 | 1,773 | 78 | 0 |
| Accrued Expenses | 508 | 467 | 754 | 1,096 | N/A |
| Other current liabilities | 0 | 794 | 764 | 1,192 | N/A |
| TOTAL | $1,335 | $3,003 | $3,290 | $2,366 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,000 | 2,000 | N/A | N/A | N/A |
| TOTAL | $2,000 | $2,000 | $N/A | $N/A | $N/A |
| Total Liabilities | $3,335 | $5,003 | $3,290 | $2,366 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,502 | 3,478 | 2,039 | N/A | N/A |
| Common Shares | 14 | 1 | 1 | 1 | N/A |
| Retained earnings | -68,729 | -67,061 | -63,738 | -61,503 | N/A |
| Other shareholders' equity | 0 | 70,340 | 69,840 | 69,839 | 0 |
| TOTAL | $44,226 | $4,476 | $7,275 | $9,458 | $N/A |
| Total Liabilities And Equity | $47,561 | $9,479 | $10,565 | $11,824 | $0 |